BRIEF-VolitionRx Limited's novel cancer diagnostic test achieves CE marking

* Volitionrx ltd - achieved CE marking on its NU.Q

colorectal cancer screening triage test on Dec. 28, 2016, paving

way for its expected launch across EU

Source text for Eikon:

Further company coverage:

Read more